Paul Schmidt

Paul Schmidt is an accomplished financial executive with extensive experience in the pharmaceutical and spirits industries. Currently serving as the Global Head of Commercial Finance at Alexion Pharmaceuticals, Inc. since March 2020, Paul previously held significant roles such as Global Head of Financial Planning & Analysis at Akcea Therapeutics and Senior Director of Finance at Intarcia Therapeutics. Earlier positions include leadership in commercial financial planning at Gilead Sciences and brand finance at Campari America. Paul’s career began at Zurich Scudder Investments in Singapore, and Paul has also consulted for Wells Fargo. Paul holds an MBA in Finance, General Management, and Entrepreneurship from The University of Chicago Booth School of Business and a BA in Sociology from the University of Vermont.